Mutations in the RNase H domain of HIV-1 reverse transcriptase affect the initiation of DNA synthesis and the specificity of RNase H cleavage in vivo. 2002

John G Julias, and Mary Jane McWilliams, and Stefan G Sarafianos, and Edward Arnold, and Stephen H Hughes
HIV Drug Resistance Program, National Cancer Institute, National Institutes of Health, P.O. Box B, Frederick, MD 21702-1201, USA.

Retroviral reverse transcriptases contain a DNA polymerase activity that can copy an RNA or DNA template and an RNase H activity that degrades the viral RNA genome during reverse transcription. RNase H makes both specific and nonspecific cleavages; specific cleavages are used to generate and remove the polypurine tract primer used for plus-strand DNA synthesis and to remove the tRNA primer used for minus-strand DNA synthesis. We generated mutations in an HIV-1-based vector to change amino acids in the RNase H domain that contact either the RNA and DNA strands. Some of these mutations affected the initiation of DNA synthesis, demonstrating an interdependence of the polymerase and RNase H activities of HIV-1 reverse transcription during viral DNA synthesis. The ends of the linear DNA form of the HIV-1 genome are defined by the specific RNase H cleavages that remove the plus- and minus-strand primers; these ends can be joined to form two-long-terminal repeat circles. Analysis of two-long-terminal repeat circle junctions showed that mutations in the RNase H domain affect the specificity of RNase H cleavage.

UI MeSH Term Description Entries
D008958 Models, Molecular Models used experimentally or theoretically to study molecular shape, electronic properties, or interactions; includes analogous molecules, computer-generated graphics, and mechanical structures. Molecular Models,Model, Molecular,Molecular Model
D008969 Molecular Sequence Data Descriptions of specific amino acid, carbohydrate, or nucleotide sequences which have appeared in the published literature and/or are deposited in and maintained by databanks such as GENBANK, European Molecular Biology Laboratory (EMBL), National Biomedical Research Foundation (NBRF), or other sequence repositories. Sequence Data, Molecular,Molecular Sequencing Data,Data, Molecular Sequence,Data, Molecular Sequencing,Sequencing Data, Molecular
D009154 Mutation Any detectable and heritable change in the genetic material that causes a change in the GENOTYPE and which is transmitted to daughter cells and to succeeding generations. Mutations
D002460 Cell Line Established cell cultures that have the potential to propagate indefinitely. Cell Lines,Line, Cell,Lines, Cell
D004279 DNA, Viral Deoxyribonucleic acid that makes up the genetic material of viruses. Viral DNA
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D001483 Base Sequence The sequence of PURINES and PYRIMIDINES in nucleic acids and polynucleotides. It is also called nucleotide sequence. DNA Sequence,Nucleotide Sequence,RNA Sequence,DNA Sequences,Base Sequences,Nucleotide Sequences,RNA Sequences,Sequence, Base,Sequence, DNA,Sequence, Nucleotide,Sequence, RNA,Sequences, Base,Sequences, DNA,Sequences, Nucleotide,Sequences, RNA
D013379 Substrate Specificity A characteristic feature of enzyme activity in relation to the kind of substrate on which the enzyme or catalytic molecule reacts. Specificities, Substrate,Specificity, Substrate,Substrate Specificities
D014158 Transcription, Genetic The biosynthesis of RNA carried out on a template of DNA. The biosynthesis of DNA from an RNA template is called REVERSE TRANSCRIPTION. Genetic Transcription
D015497 HIV-1 The type species of LENTIVIRUS and the etiologic agent of AIDS. It is characterized by its cytopathic effect and affinity for the T4-lymphocyte. Human immunodeficiency virus 1,HIV-I,Human Immunodeficiency Virus Type 1,Immunodeficiency Virus Type 1, Human

Related Publications

John G Julias, and Mary Jane McWilliams, and Stefan G Sarafianos, and Edward Arnold, and Stephen H Hughes
January 1996, The Journal of biological chemistry,
John G Julias, and Mary Jane McWilliams, and Stefan G Sarafianos, and Edward Arnold, and Stephen H Hughes
July 2004, Biochemistry,
John G Julias, and Mary Jane McWilliams, and Stefan G Sarafianos, and Edward Arnold, and Stephen H Hughes
August 2002, The Journal of biological chemistry,
John G Julias, and Mary Jane McWilliams, and Stefan G Sarafianos, and Edward Arnold, and Stephen H Hughes
October 2000, Proceedings of the National Academy of Sciences of the United States of America,
John G Julias, and Mary Jane McWilliams, and Stefan G Sarafianos, and Edward Arnold, and Stephen H Hughes
September 1993, Nucleic acids research,
John G Julias, and Mary Jane McWilliams, and Stefan G Sarafianos, and Edward Arnold, and Stephen H Hughes
August 2018, The Journal of biological chemistry,
John G Julias, and Mary Jane McWilliams, and Stefan G Sarafianos, and Edward Arnold, and Stephen H Hughes
August 2010, The Journal of biological chemistry,
John G Julias, and Mary Jane McWilliams, and Stefan G Sarafianos, and Edward Arnold, and Stephen H Hughes
January 1991, Archives of virology,
John G Julias, and Mary Jane McWilliams, and Stefan G Sarafianos, and Edward Arnold, and Stephen H Hughes
April 2013, Nucleic acids research,
John G Julias, and Mary Jane McWilliams, and Stefan G Sarafianos, and Edward Arnold, and Stephen H Hughes
January 2009, Antiviral therapy,
Copied contents to your clipboard!